2026 NPPES data Nephrology Physician NPI 1821286832 M.D
Verify on CMS →

SRI YARLAGADDA, M.D

Nephrology Physician in KANSAS CITY, Kansas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
530
Medicare Part D claims · 116 beneficiaries · Nephrology Physician avg: 1K
Generic prescribing
77%
generic claims · 23% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.8902/100
▲ 9 pts above national avg 83.1 · [object Object]

What the federal data shows

SRI YARLAGADDA, M.D reported a CMS MIPS final score of 91.8902/100 — above the 83.1 national average — and filed 530 Medicare Part D claims in 2023.

91.8902/100
MIPS score · +9 vs avg
530
Part D claims, 2023
77%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SRI YARLAGADDA, M.D's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

92 Top 37% higher than 63% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

SRI YARLAGADDA, M.D practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SRI YARLAGADDA, M.D?

High performer (top quartile)

NPI registry status

Active

Issued 10/04/2007

NPI 1821286832

Primary specialty

Nephrology Physician

Mid-sized

10,534 US NPIs in this specialty

Medicare Part D claims

530 64% vs specialty avg

2023 prescription claims

Specialty avg: 1,454

MIPS final score

91.8902/100 8.790199999999999% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Kansas

How Nephrology Physician compares to other specialties among Kansas providers

Kansas providers

Nephrology Physician share within Kansas

1. Nephrology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Nephrology Physician share within Kansas

Medicare quality performance — MIPS

SRI YARLAGADDA, M.D's 2023 MIPS final score plotted against the Nephrology Physician national average

High performer (top quartile)
MIPS Final Score
91.8902/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Nephrology Physician) — 91.8902/100 vs national avg 83.1

0%100%National avg83%91.9%
MIPS final score (Nephrology Physician) — 91.8902/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SRI YARLAGADDA, M.D appears in the CMS NPPES registry as a Nephrology Physician provider holding M.D credentials at 3901 RAINBOW BLVD, KANSAS CITY, KS, 66160, with a listed phone of (913) 588-6074. NPI 1821286832 was issued on 10/04/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what YARLAGADDA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 530 prescription claims written by this provider, covering 116 Medicare beneficiaries and totaling roughly $129K in drug spend, split 23% brand-name and 77% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.8902/100 for the 2023 performance year (Quality 75.1734), compared with the national average of 83.1.

Nephrology Physician is a mid-sized specialty nationwide, with 10,534 enrolled providers across 55 states and an average of 1,454 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3901 RAINBOW BLVD
KANSAS CITY, KS 66160

Provider Details

NPI 1821286832
Specialty Nephrology Physician
Credentials M.D
Gender Female
NPI Issued 10/04/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.8902
Final Score
Avg: 83.1
75.1734
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where SRI YARLAGADDA, M.D bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

KANSAS UNIVERSITY PHYSICIANS INC
LENEXA, KS
NEW LIBERTY HOSPITAL CORPORATION
LIBERTY, MO

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Typical

SRI YARLAGADDA, M.D — brand share 23.0%
Specialty average (est.)

23% brand-name claims vs 77% generic, on 530 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

530
Total Claims
$129K
Total Drug Cost
116
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,165
Total Day Supply
34,496
Brand vs Generic
23% brand / 77% generic
Brand Drug Cost
$119K
Generic Drug Cost
$10K

Patient Demographics

Average Patient Age
69.3 years
Avg HCC Risk Score
3.63
Gender Split
48% female / 52% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SRI YARLAGADDA, M.D prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Furosemide
78
Losartan Potassium
55
Jardiance
Empagliflozin
54
Lisinopril
35
Potassium Chloride
29
Farxiga
Dapagliflozin Propanediol
25
Amlodipine Besylate
24
Spironolactone
23
Nifedipine Er
Nifedipine
22
Carvedilol
20

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Nephrology Physician Overview

How SRI YARLAGADDA, M.D fits within the Nephrology Physician landscape nationally.

10,534
Nephrology Physician Providers in US
55
States with Nephrology Physician
1,454
Avg Claims per Provider

SRI YARLAGADDA, M.D's 530 claims are below the specialty average of 1,454.

Nearby Nephrology Physician Providers in Kansas

Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as YARLAGADDA.

Compare Nephrology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SRI YARLAGADDA, M.D's specialty?
SRI YARLAGADDA, M.D specializes in Nephrology Physician and practices in KANSAS CITY, Kansas. Credentials: M.D.
How much does SRI YARLAGADDA, M.D prescribe under Medicare Part D?
In 2023, SRI YARLAGADDA, M.D wrote 530 Medicare Part D claims totaling $129K in drug costs for 116 beneficiaries.
What is SRI YARLAGADDA, M.D's Medicare quality score?
SRI YARLAGADDA, M.D has a CMS MIPS Final Score of 91.8902/100 (Quality: 75.1734). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is SRI YARLAGADDA, M.D located?
SRI YARLAGADDA, M.D is located at 3901 RAINBOW BLVD, KANSAS CITY, KS, 66160. Phone: (913) 588-6074.
What is SRI YARLAGADDA, M.D's NPI number?
SRI YARLAGADDA, M.D's National Provider Identifier (NPI) is 1821286832, issued on 10/04/2007.
Does SRI YARLAGADDA, M.D prescribe more brand-name or generic drugs?
SRI YARLAGADDA, M.D's prescribing is 23% brand-name and 77% generic drugs by claim count, with $119K in brand drug costs.
How many Nephrology Physician providers are there in the US?
There are 10,534 Nephrology Physician providers across 55 states in the US. The average Nephrology Physician provider writes 1,454 Medicare Part D claims per year.
What drugs does SRI YARLAGADDA, M.D prescribe most often?
Based on 2023 Medicare Part D data, SRI YARLAGADDA, M.D's most frequently prescribed drugs include Furosemide, Losartan Potassium, Jardiance. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SRI YARLAGADDA, M.D accept Medicare?
SRI YARLAGADDA, M.D appears in CMS Medicare data with 530 Part D claims and 116 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SRI YARLAGADDA, M.D's credentials?
SRI YARLAGADDA, M.D's NPI is 1821286832 with credentials M.D. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology